UCSF, UC Berkeley Scientists Join Forces in New Glenn Center for Aging Research
Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases.
University of California San Francisco
Give to UCSFResearchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases.
Video games that make you smarter. A chip that can identify mysterious illnesses in hours. These are some of the topics top UCSF scientists will discuss at this year’s free UCSF Dreamforce track on Oct. 15.
Five UCSF neuroscientists have received research grants in the highly competitive first wave of National Institutes of Health (NIH) awards to support President Obama’s BRAIN Initiative.
An unprecedented, public-private partnership funded by the Department of Defense is being launched to drive the development of better-run clinical trials and may lead to the first successful treatments for traumatic brain injury.
UCSF researchers have used brain scans to predict how young children learn to read, giving clinicians a possible tool to spot children with dyslexia and other reading difficulties before they experience reading challenges.
When members of the Neurointensive Care (Neuro ICU) Unit at the UCSF Medical Center started receiving the ALS Ice Bucket Challenge from various sources, they jumped at the chance to accept the challenge and to donate to ALS research.
On a cold and windy afternoon at the Parnassus campus, UCSF Chancellor Sam Hawgood, MBBS, accepted the #ALSIceBucketChallenge, dunking himself in ice water and making a personal donation to the ALS Association.
A new study suggests that colds and other minor infections may temporarily increase stroke risk in children.
UCSF researchers have identified cells’ unique features within the developing human brain, using the latest technologies for analyzing gene activity in individual cells, and have demonstrated that large-scale cell surveys can be done much more efficiently and cheaply than was previously thought possible.
Researchers at UCSF have found that children with sensory processing disorders have decreased structural brain connections in specific sensory regions different than those in autism, further establishing SPD as a clinically important neurodevelopmental disorder.
Researchers at UCSF have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
UCSF Medical Center is among the nation's premier hospitals for the 13th consecutive year, ranking as the eighth best hospital in the country according to U.S. News & World Report.
A brain region that is vital for memory and shrinks in Alzheimer’s disease patients also is likely to be smaller in those whose white blood cells have shorter DNA-protecting end caps – called telomeres – according to a study by Stanford and UCSF researchers.
A team led by UCSF scientists has identified eight drugs that may stimulate nervous system repair in multiple sclerosis (MS).
UCSF researchers have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.
In a new study by UC San Francisco scientists, running, when accompanied by visual stimuli, restored brain function to normal levels in mice that had been deprived of visual experience in early life.
Parents who have a child with autism spectrum disorder (ASD) are about one third less likely to have more children than families without an affected child, according to a study led by a UC San Francisco researcher.
The Brain Health Registry – led by top researchers at UC San Francisco – is a new, groundbreaking, web-based project designed to speed up cures for Alzheimer’s, Parkinson’s and other brain disorders.
The New York Times Health for Tomorrow conference, held at UCSF, featured experts from the University of California and across the country, addressing the changing landscape of health care.
Scientists and physicians at UCSF are leading a $26 million, multi-institutional research program to better understand and treat a range of common, debilitating psychiatric disorders.
Funded through President Obama's Brain Initiative, a UCSF-led team is embarking on a $26 million project to develop a revolutionary and long-lasting treatment for depression, anxiety disorders, addiction and other neuropsychiatric disorders.
A scientific team led by the Gladstone Institutes and UCSF has discovered that a common form of a gene already associated with long life also improves learning and memory.
Young blood really does rejuvenate the brain, at least in mice, raising hopes that molecules in the blood may be identified that can do the same for humans, according to a new UCSF study.
Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as “astrocytes,” because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UCSF researchers.
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
Four UCSF-affiliated researchers are among 102 recipients of the Presidential Early Career Awards for Scientists and Engineers.
A new online project led by researchers at UCSF promises to dramatically cut the time and cost of conducting clinical trials for brain diseases, while also helping scientists analyze and track the brain functions of thousands of volunteers over time.
The ALS Treatment and Research Center, a clinical practice of the Department of Neurology at UCSF and an ALS Association-certified Center of Excellence, is expanding its support for the community of people facing amyotrophic lateral sclerosis.
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UCSF.